Costs for cancer drugs, combos face increasing scrutiny
This article was originally published in Scrip
Executive Summary
As more effective and more expensive cancer therapies hit the US market, doctors and payers are taking a closer look at the cost of oncology drugs – even potentially life-saving medicines – out of fear that the health care system won't be able to support the high price of treatment.